Five grams of white powder a day. That is the exact dose now linked to real, measurable muscle gains in women well past menopause, according to the most complete analysis to date on creatine and women’s health.
Creatine has spent decades as a gym-bro staple, the go-to supplement for bodybuilders and sprinters chasing extra reps and explosive power. But a systematic review and meta-analysis just published in the Journal of the International Society of Sports Nutrition pooled seven randomized controlled trials and 608 postmenopausal women to answer a question almost nobody had asked before: does creatine actually do anything for women whose muscle and bone are already fading with age?
The answer is yes, but only under specific conditions. When creatine monohydrate was combined with structured resistance training, women gained an average of 0.37 kilograms of lean mass and, more strikingly, 7.5 kilograms of extra strength on the leg press compared to a placebo group doing the exact same workouts. That is roughly a 6 to 8% strength boost on top of what training alone delivers, translating into very ordinary wins: getting out of a chair more easily, climbing a flight of stairs without stopping, carrying groceries without straining.
The dose mattered enormously. Trials that gave women 5 grams a day or more, especially after an initial loading phase of about 20 grams daily for five days, consistently showed benefits. Trials that used only 1 to 3 grams a day, and skipped resistance training altogether, showed essentially nothing. Creatine without exercise did not move the needle. In two long trials lasting one and two years respectively, women who took low doses without lifting weights ended up no different from the placebo group.
This matters because menopause hits skeletal muscle unusually hard. Falling estrogen accelerates the loss of muscle mass and strength, a process researchers already call “anabolic resistance,” on top of an average bone loss of roughly 1% per year. Sarcopenia, frailty and fall risk are not abstract concerns for women in their 50s, 60s and 70s; they are the difference between staying independent and needing help with daily tasks. The stakes explain why a supplement long associated with young male athletes is now being tested seriously in an entirely different population.
Bone density, though, is where the hype runs out. The same meta-analysis found no meaningful improvement in bone mineral density from creatine, even when paired with training, across some of the longest and best-designed trials in the dataset. One study did find a smaller decline in femoral neck density among creatine users, but total hip and spine bone mass stayed unchanged. Creatine builds muscle, not bone, at least at the doses tested so far.
Safety, meanwhile, looks reassuring. Across the pooled trials, side effects were mild, mostly occasional bloating, and no more common than with placebo. Kidney and liver markers stayed normal throughout studies lasting up to two years, echoing a broader 2025 analysis of 685 clinical trials involving more than 26,000 participants that found no elevated risk of any adverse event with creatine supplementation.
The authors are candid about the limits of their own conclusions: only seven trials, modest sample sizes, and real variation in dosing protocols across studies. Still, for a woman in her 60s already lifting weights, the takeaway is concrete. Five grams a day, paired with training two to three times a week, is what the evidence currently supports, not a magic solution on its own.
Source: Naddafha S, Antonio J, Kreider RB, Stout JR. “Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis.” Journal of the International Society of Sports Nutrition, 2026;23(1):2668435. DOI: 10.1080/15502783.2026.2668435.
